Artelo Biosciences, Inc. (ARTL)

Artelo Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Nov 30, 2021
Cash & Equivalents	0.6	2.34	2.82	6.89	14.05
Short-Term Investments	-	-	7.61	10.65	10.79
Cash & Short-Term Investments	0.6	2.34	10.43	17.53	24.84
Cash Growth	-74.34%	-77.58%	-40.53%	-29.42%	146.81%
Other Current Assets	0.1	0.22	0.55	0.79	0.51
Total Current Assets	0.7	2.56	10.98	18.32	25.36
Net Property, Plant & Equipment	0.06	0.1	0.02	0.06	0.08
Other Intangible Assets	2.04	2.04	2.04	2.04	2.04
Long-Term Investments	-	-	-	-	1.52
Other Long-Term Assets	0	0	0	0	0
Total Assets	2.8	4.7	13.04	20.42	29
Accounts Payable	3.04	1.68	1.24	0.91	0.59
Accrued Expenses	0.02	-	-	-	-
Short-Term Debt	0.61	-	-	-	-
Current Portion of Leases	0.04	0.04	0.02	0.04	0.03
Other Current Liabilities	0.35	0.06	0.03	0.05	0.04
Total Current Liabilities	4.04	1.77	1.29	1	0.66
Long-Term Leases	0.03	0.07	-	0.02	0.06
Total Long-Term Liabilities	0.03	0.07	-	0.02	0.06
Total Liabilities	4.07	1.84	1.29	1.02	0.72
Common Stock	-	-	0	0	0.04
Additional Paid-in Capital	62.01	53.19	52.26	50.68	47.72
Accumulated Other Comprehensive Income	-0.27	-0.2	-0.2	-0.25	-0.02
Retained Earnings	-63.02	-50.14	-40.31	-31.02	-19.45
Shareholders' Equity	-1.27	2.86	11.75	19.4	28.29
Total Liabilities & Equity	2.8	4.7	13.04	20.42	29
Total Debt	0.68	0.1	0.02	0.06	0.09
Net Cash (Debt)	-0.08	2.23	10.4	17.47	24.75
Net Cash Growth	-	-78.53%	-40.45%	-29.42%	148.25%
Net Cash Per Share	-0.23	12.48	63.18	111.00	-
Book Value	-1.27	2.86	11.75	19.4	28.29
Book Value Per Share	-3.71	15.96	71.37	123.28	-
Tangible Book Value	-3.31	0.82	9.71	17.36	26.25
Tangible Book Value Per Share	-9.65	4.57	58.99	110.33	-

Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q